Letteratura scientifica selezionata sul tema "Addictovigilance"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Consulta la lista di attuali articoli, libri, tesi, atti di convegni e altre fonti scientifiche attinenti al tema "Addictovigilance".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Articoli di riviste sul tema "Addictovigilance":
Jouanjus, Emilie, Joëlle Micallef, Michel Mallaret e Maryse Lapeyre-Mestre. "Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions". International Journal of Neuropsychopharmacology 22, n. 8 (13 giugno 2019): 528–30. http://dx.doi.org/10.1093/ijnp/pyz033.
Chavant, François, Alexandra Boucher, Reynald Le Boisselier, Sylvie Deheul e Danièle Debruyne. "New Synthetic Drugs in Addictovigilance". Therapies 70, n. 2 (marzo 2015): 179–89. http://dx.doi.org/10.2515/therapie/2015001.
Chavant, François, Alexandra Boucher, Reynald Le Boisselier, Sylvie Deheul e Danièle Debruyne. "Nouvelles drogues de synthèse en addictovigilance". Therapies 70, n. 2 (marzo 2015): 167–78. http://dx.doi.org/10.2515/therapie/2014235.
Jouanjus, Emilie, Valérie Gibaja, Jean-Pierre Kahn, Françoise Haramburu e Amélie Daveluy. "Comment identifier un signal en addictovigilance ?" Therapies 70, n. 2 (marzo 2015): 113–22. http://dx.doi.org/10.2515/therapie/2015009.
Daveluy, Amélie, Joëlle Perri-Plandé, Marie Baumevieille, Alexandre Peyré e Ghada Miremont-Salamé. "Addictovigilance dans les départements d’Outre-Mer". Therapies 73, n. 6 (dicembre 2018): 565. http://dx.doi.org/10.1016/j.therap.2018.09.062.
Gibaja, Valérie, Audrey Fresse, Juliana Tournebize e Maryse Lapeyre Mestre. "Poudre d’opium et addictovigilance : état des lieux". Therapies 76, n. 2 (marzo 2021): 164. http://dx.doi.org/10.1016/j.therap.2021.01.015.
Gentile, Gaétan, Maeva Jego, Michel Spadari, Karolina Griffiths, Emilie Jouanjus e Joëlle Micallef. "Identification and tracking of Addictovigilance signals in general practice: which interactions between the general practitioners and the French Addictovigilance Network?" Fundamental & Clinical Pharmacology 32, n. 6 (5 agosto 2018): 643–51. http://dx.doi.org/10.1111/fcp.12401.
Lapeyre-Mestre, Maryse. "Identification and tracking of addictovigilance signals in general practice: which interactions between the general practitioners and the French addictovigilance network?" Fundamental & Clinical Pharmacology 32, n. 6 (11 novembre 2018): 641–42. http://dx.doi.org/10.1111/fcp.12425.
Jouanjus, Emilie, Valérie Gibaja, Jean-Pierre Kahn, Françoise Haramburu e Amélie Daveluy. "Signal Identification in Addictovigilance: the Functioning of the French System". Therapies 70, n. 2 (marzo 2015): 123–31. http://dx.doi.org/10.2515/therapie/2015011.
Batisse, A., C. Eiden, R. Le Boisselier, J. Tournebize, A. Boucher, B. Fauconneau, S. Deheul et al. "New psychoactive substances: French addictovigilance data between 2009 and 2017". Toxicologie Analytique et Clinique 31, n. 2 (maggio 2019): S42—S43. http://dx.doi.org/10.1016/j.toxac.2019.03.057.
Tesi sul tema "Addictovigilance":
Pauly, Vanessa. "Evaluation de l'abus et du détournement des médicaments psychoactifs en addictovigilance : analyse de bases de données hétérogènes". Thesis, Aix-Marseille 2, 2011. http://www.theses.fr/2011AIX20696.
The objective of this work was to analyze abuse, dependence and diversion of psychoactive medicines in real settings using jointly different indicators issued from mixed datasources in order to present a synthetic vision. The datasources used in this work are issued from the tools developed by the Centres for Evaluation and Information on Pharmacodependency (CEIP). They allow to measure directly drug abuse with specific populations of dependent patients or under opiate treatment (OPPIDUM (Observation of the Illicit Psychotropic Products or Diverted from their Medicinal Use) survey)). These tools also allow to measure the diversion via the measure of the phenomenon of “doctor shopping” (overlapping of prescriptions) and the measure of the number of patients presenting a deviant behaviour from general health insurance databases; then they measure diversion through falsified prescriptions presented at pharmacies (the OSIAP (Forged prescriptions indicating potential abuse) survey).This multisources approach has been firstly applied to analyse abuse and diversion of clonazepam (1st publication). This study has highlighted the emerging problem of diversion of clonazepam, after flunitrazepam and has also illustrated the difficulty of analysing with consistency the information gathered by these different datasources. A good system for controlling drug diversion and abuse has to allow analysing trends. We have so proposed a classification method aiming at revealing profile of subjects with deviant behaviour to use it on an evolutive manner so as to study diversion of methylphenidate on a four year period (2nd publication). This classification method has then been applied jointly with a method measuring the “doctor shopping” to analyse diversion of High Dosage Buprenorphine (HDB) (3rd publication). This study has revealed an important problem of diversion of HDB, has also demonstrated that the two methods were globally concordant and has allowed to evaluate their advantages for the controlling of the abuse and diversion of prescription drugs. These two last methods have then been analysed jointly with data from the OPPIDUM and OSIAP surveys to allow to study and compare diversion of benzodiazepine drugs (4th publication) and opioids drugs (5th publication). This multisource approach allows to limit biases linked to each method seen individually. Our work points out the relevance of such a multisources system to estimate the abuse of a prescription drug and to compare it with the other substances. Nevertheless, the development of such a system applied to the domain of the drug dependency is relatively new, and requires improvements concerning the integration of the other sources of data and the methodology used to join and synthetize the information obtained. Finally, such a system "multi-sources” has the potential to exist and to make a real contribution to the domain of the drug dependency in France
Omgba-Noah, André Christian. "L’économie morale de l’accompagnement médico-social : étude de deux dispositifs de lutte contre les addictions". Electronic Thesis or Diss., Bourgogne Franche-Comté, 2023. http://www.theses.fr/2023UBFCC038.
This thesis analyzes the orientation of the productive action of medico-social professionals based on the probability of a moral economy of support specific to this field of intervention. After having exposed and circumscribed the definitional framework in which this community of values fits, we rely on empirical work carried out in two systems for combating addictions (TAPAJ and the Aller-vers mobile team). The objective of this contribution is to try to show that these professionals are not moved only by a rational will which disposes them to apply, without mediation, the laws which govern their environment. They are also sometimes caught and seized in a universe bathed in emotions and affects, carrying their action into quasi-vocational dimensions. This moral economy, therefore, shapes the ethics of care which is a theoretical-practical philosophy mainly considering care as being at the heart of concerns